XORTX Therapeutics Inc. (XRTX) Stock Forecast
XRTX analyst forecast
as of October 18, 2026- Analyst consensus
- —
- Price target
- $14.04 average of analyst targets
- Upside to target
- +1,031.9% from the latest close
- Next earnings
- November 13, 2026
- 52-week range
- $1.24 – $3.75
XRTX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
XRTX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$0.48 | −$0.48 | −$0.48 | −$0.93 | +48.0% | 1 |
| Next fiscal year (2027) | $1.10 | $1.10 | $1.10 | −$0.48 | +328.4% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
XRTX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current fiscal year (2026) | $0 | $0 | $0 | 0.0% | — |
| Next fiscal year (2027) | $22.0M | $22.0M | $22.0M | +392.3% | 1 |
XRTX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
XRTX revenue: reported and forecast
XRTX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current fiscal year (2026) | −$1.22 | −$1.22 | −$1.22 | $0.00 | −$0.48 | −60.4% | 0 up · 0 down |
| Next fiscal year (2027) | $1.00 | $1.00 | $1.00 | $0.00 | $1.10 | +10.0% | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
XRTX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; XRTX beat in 6 of 7.
What analysts expect from XRTX
The average price target is $14.04, 1,031.9% above the latest close of $1.24. Analysts expect earnings of −$0.48 per share for 2026, +48.0% from a year earlier. For 2027 the average estimate is $1.10 per share on revenue of $22.0 million. XORTX Therapeutics beat the EPS estimate in 6 of the last 7 quarters.
Related: XRTX income statement, XRTX key metrics, XRTX chart. See the XRTX stock overview for the latest quote and news.
XRTX forecast FAQ
What is XORTX Therapeutics's price target?
The average analyst price target for XORTX Therapeutics is $14.04, 1,031.9% above the latest close of $1.24.
What is XORTX Therapeutics's EPS forecast?
Analysts forecast −$0.48 per share for 2026 (range −$0.48 to −$0.48); for 2027 the estimate is $1.10.
When does XORTX Therapeutics report earnings?
XORTX Therapeutics is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
Does XORTX Therapeutics usually beat earnings estimates?
XORTX Therapeutics reported EPS at or above the analyst estimate in 6 of the last 7 quarters.